This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Despite these limitations, the results of this study are in line with another previous small randomized trial conducted in 2003. This study has been heralded as “ The Death of the GI Cocktail ” however it is remarkably similar to the study from 2003 that also favored antacid alone.
While aspiration was not previously addressed head-on in CAP guidelines, new data prompted the 2019 IDSA CAP guideline authors to include the following question: Question 10: In the Inpatient Setting, Should Patients with Suspected Aspiration Pneumonia Receive Additional Anaerobic Coverage beyond Standard Empiric Treatment for CAP?
While aspiration was not previously addressed head-on in CAP guidelines, new data prompted the 2019 IDSA CAP guideline authors to include the following question: Question 10: In the Inpatient Setting, Should Patients with Suspected Aspiration Pneumonia Receive Additional Anaerobic Coverage beyond Standard Empiric Treatment for CAP?
By incorporating these measures into both inpatient and outpatient quality reporting, CMS is promoting a more equitable health care system and ensuring that interventions are targeted to reduce health disparities. 1 This expansion will enable health care providers to identify at-risk populations and develop targeted interventions.
While aspiration was not previously addressed head-on in CAP guidelines, new data prompted the 2019 IDSA CAP guideline authors to include the following question: Question 10: In the Inpatient Setting, Should Patients with Suspected Aspiration Pneumonia Receive Additional Anaerobic Coverage beyond Standard Empiric Treatment for CAP?
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content